Abstract
Molecular imaging allows clinicians to visualize the progression of tumours and obtain relevant information for patient diagnosis and treatment1. Owing to their intrinsic optical, electrical and magnetic properties, nanoparticles are promising contrast agents for imaging dynamic molecular and cellular processes such as protein–protein interactions, enzyme activity or gene expression2. Until now, nanoparticles have been engineered with targeting ligands such as antibodies and peptides to improve tumour specificity and uptake. However, excessive loading of ligands can reduce the targeting capabilities of the ligand3,4,5 and reduce the ability of the nanoparticle to bind to a finite number of receptors on cells6. Increasing the number of nanoparticles delivered to cells by each targeting molecule would lead to higher signal-to-noise ratios and would improve image contrast. Here, we show that M13 filamentous bacteriophage can be used as a scaffold to display targeting ligands and multiple nanoparticles for magnetic resonance imaging of cancer cells and tumours in mice. Monodisperse iron oxide magnetic nanoparticles assemble along the M13 coat, and its distal end is engineered to display a peptide that targets SPARC glycoprotein, which is overexpressed in various cancers. Compared with nanoparticles that are directly functionalized with targeting peptides, our approach improves contrast because each SPARC-targeting molecule delivers a large number of nanoparticles into the cells. Moreover, the targeting ligand and nanoparticles could be easily exchanged for others, making this platform attractive for in vivo high-throughput screening and molecular detection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Weissleder, R. Molecular imaging in cancer. Science STKE 312, 1168–1171 (2006).
Massoud, T. & Gambhir, S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17, 545–580 (2003).
Gu, F. et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc. Natl Acad. Sci. USA 105, 2586–2591 (2008).
Hamblett, K. J. et al. Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate. Clin. Cancer Res. 10, 7063–7070 (2004).
Hlavacek, W., Posner, R. & Perelson, A. Steric effects on multivalent ligand-receptor binding: exclusion of ligand sites by bound cell surface receptors. Biophys. J. 76, 3031–3043 (1999).
Ruoslahti, E., Bhatia, S. N. & Sailor, M. J. Targeting of drugs and nanoparticles to tumors. J. Cell Biol. 188, 759–768 (2010).
Scott, J. K. & Smith, G. P. Searching for peptide ligands with an epitope library. Science 249, 386–390 (1990).
Larocca, D., Witte, A., Johnson, W., Pierce, G. F. & Baird, A. Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum. Gene Ther. 9, 2393–2399 (1998).
Frenkel, D. & Solomon, B. Filamentous phage as vector-mediated antibody delivery to the brain. Proc. Natl Acad. Sci. USA 99, 5675–5679 (2002).
Barry, M. A., Dower, W. J. & Johnston, S. A. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nature Med. 2, 299–305 (1996).
Arap, W., Pasqualini, R. & Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279, 377–380 (1998).
Mao, C. B. et al. Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires. Science 303, 213–217 (2004).
Lee, Y. J. et al. Fabricating genetically engineered high-power lithium-ion batteries using multiple virus genes. Science 324, 1051–1055 (2009).
Nam, Y. S. et al. Biologically templated photocatalytic nanostructures for sustained light-driven water oxidation. Nature Nanotech. 5, 340–344 (2010).
Kelly, K. A., Waterman, P. & Weissleder, R. In vivo imaging of molecularly targeted phage. Neoplasia 8, 1011–1018 (2006).
Clark, C. J. & Sage, E. H. A prototypic matricellular protein in the tumor microenvironment—where there's SPARC, there's fire. J. Cell Biochem. 104, 721–732 (2008).
Yoo, P. J. et al. Spontaneous assembly of viruses on multilayered polymer surfaces. Nature Mater. 5, 234–240 (2006).
Park, J. et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nature Mater. 3, 891–895 (2004).
Shen, T., Weissleder, R., Papisov, M., Bogdanov, A. Jr & Brady, T. J. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn. Reson. Med. 29, 599–604 (1993).
Fan, X. et al. Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn. Reson. Med. 45, 1046–1055 (2001).
Lee, N. et al. Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets. Proc. Natl Acad. Sci. USA 108, 2662–2667 (2011).
Jung, C. W. & Jacobs, P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imaging 13, 661–674 (1995).
Brekken, R. & Sage, E. SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol. 19, 569–580 (2000).
Lee, J. H. et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nature Med. 13, 95–99 (2007).
Yoon, T. J., Lee, H., Shao, H. & Weissleder, R. Highly magnetic core–shell nanoparticles with a unique magnetization mechanism. Angew. Chem. Int. Ed. Engl. 50, 4663–4666 (2011).
Haun, J. B., Devaraj, N. K., Hilderbrand, S. A., Lee, H. & Weissleder, R. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. Nature Nanotech. 5, 660–665 (2010).
von Maltzahn, G. et al. Nanoparticles that communicate in vivo to amplify tumour targeting. Nature Mater. 10, 545–552 (2011).
Pasqualini, R. & Ruoslahti, E. Organ targeting in vivo using phage display peptide libraries. Nature 380, 364–366 (1996).
Laakkonen, P., Porkka, K., Hoffman, J. & Ruoslahti, E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nature Med. 8, 751–755 (2002).
Kelly, K. et al. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ. Res. 96, 327–336 (2005).
Schellenberger, E. A., Sosnovik, D., Weissleder, R. & Josephson, L. Magneto/optical annexin V, a multimodal protein. Bioconjug. Chem. 15, 1062–1067 (2004).
Kellar, K. E. et al. Important considerations in the design of iron oxide nanoparticles as contrast agents for TI-weighted MRI and MRA. Acad. Radiol. 9 (Suppl 1), S34–37 (2002).
Acknowledgements
This work was supported by the NIH Center for Cancer Nanotechnology Excellence U54- CA151884 and NIH NCI RO1 CA137071. The authors thank J. Roy for assistance with MRI and F. Reynolds for excellent technical assistance. The authors thank M. Bevard for immunohistochemistry assistance and D. Pheasant and the Biophysical Instrumentation Facility for use of the DLS. The authors also thank Jennifer Hsieh with help with XRD. The authors acknowledge the Center for Materials Science and Engineering for the use of the ICP-AES and TEM and the Koch Institute Swanson Biotechnology Center for DNA sequencing.
Author information
Authors and Affiliations
Contributions
D.G., K.A.K. and A.M.B. conceived and designed the experiments. D.G., Y.L. and S.T. performed experiments. D.G., Y.L., S.T. and A.G.K. contributed new reagents. D.S.Y. conducted high-resolution transmission electron microscopy. D.G. and K.A.K. analysed the data. D.G., K.A.K. and A.M.B. co-wrote the paper.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary information
Supplementary information (PDF 1796 kb)
Rights and permissions
About this article
Cite this article
Ghosh, D., Lee, Y., Thomas, S. et al. M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. Nature Nanotech 7, 677–682 (2012). https://doi.org/10.1038/nnano.2012.146
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nnano.2012.146
This article is cited by
-
Nanomaterial-based contrast agents
Nature Reviews Methods Primers (2023)
-
Facile fabrication of palladium and ruthenium nanoparticles incorporated into core–shell: investigation of proliferation and apoptosis induction in prostate cancer cells
Journal of Nanoparticle Research (2023)
-
M13 phage: a versatile building block for a highly specific analysis platform
Analytical and Bioanalytical Chemistry (2023)
-
Nanotechnological strategies for prostate cancer imaging and diagnosis
Science China Chemistry (2022)
-
Fabrication and Molecular Modeling of Navette-Shaped Fullerene Nanorods Using Tobacco Mosaic Virus as a Nanotemplate
Molecular Biotechnology (2022)